Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
Actual shortage: | 251 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-FINASTERIDE | 5MG | TABLET | Resolved | 2021-09-30 | 2021-10-07 | 146459 |
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2021-09-30 | 2021-11-11 | 146456 |
TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-09-30 | 2021-11-11 | 146449 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-09-30 | 2022-01-20 | 146446 |
ACT AMLODIPINE | 10MG | TABLET | Resolved | 2021-09-30 | 2021-10-07 | 146443 |
CEFOXITIN FOR INJECTION | 2G | POWDER FOR SOLUTION | Resolved | 2021-09-30 | 2021-10-07 | 146440 |
TEVA-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-09-30 | 2021-10-21 | 146437 |
TEVA-TEMOZOLOMIDE | 250MG | CAPSULE | Resolved | 2021-09-30 | 2021-10-21 | 146434 |
TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Resolved | 2021-09-23 | 2021-11-25 | 146128 |
FENTORA | 800MCG | TABLET (EFFERVESCENT) | Resolved | 2021-09-23 | 2021-10-28 | 146125 |
TEVA-ATOMOXETINE | 80MG | CAPSULE | Resolved | 2021-09-23 | 2022-03-24 | 146122 |
TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2021-09-23 | 2021-10-07 | 146118 |
FENTORA | 400MCG | TABLET (EFFERVESCENT) | Resolved | 2021-09-23 | 2021-10-28 | 146115 |
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2021-09-23 | 2021-11-18 | 146112 |
TEVA-BISOPROLOL | 10MG | TABLET | Resolved | 2021-09-23 | 2021-11-11 | 146101 |
TEVA-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2021-09-23 | 2022-05-19 | 146098 |
TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-09-23 | 2021-10-28 | 146095 |
TEVA-AMPHETAMINE XR | 20MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-09-23 | 2021-10-14 | 146092 |
ACT EXEMESTANE | 25MG | TABLET | Resolved | 2021-09-23 | 2021-11-18 | 146089 |
TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-09-16 | 2021-11-11 | 145791 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-02-13 | 2020-02-13 | 106148 |
TEVA-ATENOLOL | 100MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106145 |
TEVA-ATENOLOL | 50MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106142 |
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
TEVA-LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
TEVA-QUININE | 300MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104294 |
NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
TEVA-ARIPIPRAZOLE | 5MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104283 |
ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
TEVA-ARIPIPRAZOLE | 5MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104263 |